
Brent Fraser
Vice President, Pharmaceutical Reviews

Accessible from
anywhere in the world
Tuesday October 6th -
Thursday October 8th 2020
The Canadian pharma market landscape is being transformed at an unprecedented pace. Position your organization to succeed with critical insights on navigating the upcoming PMPRB pricing regulations, the new CADTH drug review process, and the impact of a new provincial approach to increasing the use of biosimilars.
Hear from CADTH, pCPA, INESSS, Pfizer, Boehringer Ingelheim, Eli Lilly and more!
Take advantage of this unprecedented opportunity to network with a much larger audience of your peers in an interactive learning environment and gain valuable insights from thought leaders and pharma market experts to optimize and update your market access strategy.
Discover how the visionaries and leaders behind the world’s top pharma organizations plan to implement and leverage the latest regulatory and market developments for their current and future market access strategies. Use proven strategies from 6 case studies and 7 exclusive panel discussions. Connect with 30+ market access speakers from both industry and government and benchmark your market access strategies against them.
The 2020 Market Access Summit connects you with exclusive knowledge from industry leaders at the touch of a button.
In addition to this leading-edge, supersized content, we are excited to share this as a virtual immersive experience that offers you key benefits including:
Strategy Institute enables senior executives to access cutting edge strategic and technological content, in an environment that is conducive to forging lasting business relationships.
Meet hundreds of senior pharmaceutical leaders at this annual marquee event. Build your pipeline with sales leads by taking advantage of one of our limited sponsorship opportunities.
Tuesday October 6th -
Thursday October 8th 2020
145 Days Left
Accessible from
anywhere in the world